SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
STAA

Staar Surgical Co (STAA)

NASDAQ: STAA · USD
Healthcare · Medical Instruments & Supplies
$24.22-$0.81 (-3.24%)
 
Market cap
$1.22B
Insider Score
Analyst consensus
Website
Market Cap$1.22B-11.4%
Revenue (ttm)$328.27M
Net Income$530.00K
EPS$0.01
Shares Out50.20M
PE Ratio2422.00
Forward PE21.39
Dividendn/a
Ex-Dividend Daten/a
Volume585,633
Open$24.73
Previous Close$25.03
Day's Range$23.86 - $25.08
52-Week Range$15.59 - $35.87
Beta1.20
AnalystsBuy
Price Target$28.56(+17.90%)
Earnings DateNov 4, 2026

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Address
25510 Commercentre Drive, Lake Forest, CA, 92630, United States
Market Cap
1.22 billion
Employees
921
Industrial Classification
Medical Instruments & Supplies

Analyst consensus

Moderate Buy
2 Buy0 Hold0 SellAvg target $28.63 (+18.2%)

2 firms rating STAA in the last 3 months, one vote each. Issuer-paid research is not counted.

1 Day
-3.24%
5 Days
-8.22%
1 Month
+7.69%
6 Months
-25.41%
1 Year
-11.44%

$STAA stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in STAA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by STAA's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

STAA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New STAA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to STAA from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from STAA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
81
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XHEState Street SPDR S&P Health Care Equipment ETF1.68%
SIXLETC 6 Meridian Low Beta Equity ETF0.47%
PSCHInvesco S&P SmallCap Health Care ETF0.42%
ETHOAmplify Etho Climate Leadership U.S. ETF0.42%
SMIZZacks Small/Mid Cap ETF0.41%
DMRMDeltaShares S&P 400 Managed Risk ETF0.28%
SQLVRoyce Quant Small-Cap Quality Value ETF0.24%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.23%
STSBiShares Factors US Small Blend Style ETF0.19%
ESIXState Street SPDR S&P SmallCap 600 ESG ETF0.11%
QVMSInvesco S&P SmallCap 600 QVM Multi-factor ETF0.08%
SMMViShares MSCI USA Small-Cap Min Vol Factor ETF0.07%

Weight is the stock’s share of each fund’s holdings.